Treatment of systemic necrotizing vasculitides in patients≥65 years old: Results of the multicenter randomized CORTAGE trial

Pagnoux, Christian; Quéméneur, T.; Ninet, J.; Perrodeau, Élodie; Diot, Élisabeth; Kyndt, X.; Wazières, B. de; Reny, Jean‐Luc; Puéchal, Xavier; Leberruyer, P.-Y.; Lidove, Olivier; Vanhille, P; Godmer, Pascal; Albath-Sadiki, A.; Bienvenu, Boris; Cohen, Pascal; Mouthon, Luc; Ravaud, Philippe; Guillevin, Loı̈c

doi:10.1016/j.lpm.2013.02.069

La Presse Médicale

2013

DOI: 10.1016/j.lpm.2013.02.069

|View full text |Cite

Treatment of systemic necrotizing vasculitides in patients≥65 years old: Results of the multicenter randomized CORTAGE trial

Christian Pagnoux¹,

T. Quéméneur²,

J. Ninet³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

2015

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 8 publications

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Treatment of Severe and/or Refractory ANCA-Associated Vasculitis

Guillevin

2014

Curr Rheumatol Rep

View full text Add to dashboard Cite

Most patients presenting with systemic necrotizing vasculitides improve when they are adequately treated. The presence of life-threatening manifestations or visceral involvement modifying organ function characterizes severe vasculitis, confirmed by disease-severity scores. Sequelae cannot always be predicted and prevented but organ involvement present at disease onset requires rapid therapeutic intervention. Some patients present a persistent active disease, which does not respond to treatments and deserve other drugs or combination of drugs. The therapeutic options for severe and/or relapsing and refractory diseases are described.

show abstract

Treatment of Severe and/or Refractory ANCA-Associated Vasculitis

Guillevin

2014

Curr Rheumatol Rep

View full text Add to dashboard Cite

show abstract

Vascularites associées aux anticorps anticytoplasme des polynucléaires neutrophiles : nouveaux traitements

Guillevin

2014

Réanimation

View full text Add to dashboard Cite

Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors

Samson¹,

Puéchal²,

Devilliers³

et al. 2014

Autoimmunity Reviews

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Treatment of systemic necrotizing vasculitides in patients≥65 years old: Results of the multicenter randomized CORTAGE trial

Cited by 8 publications

References 37 publications

Treatment of Severe and/or Refractory ANCA-Associated Vasculitis

Treatment of Severe and/or Refractory ANCA-Associated Vasculitis

Vascularites associées aux anticorps anticytoplasme des polynucléaires neutrophiles : nouveaux traitements

Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors

Contact Info

Product

Resources

About